SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-001099
Filing Date
2023-01-04
Accepted
2023-01-04 21:25:59
Documents
2
Period of Report
2023-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm231728-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm231728-5_4seq1.xml 4 4026
2 EXHIBIT 24 tm231728d5_ex24.htm EX-24 8996
  Complete submission text file 0001104659-23-001099.txt   14519
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Issuer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NUVEEN 333 W. WACKER DR. CHICAGO IL 60606
Business Address
Lorenz Kevin (Reporting) CIK: 0001772558 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35366 | Film No.: 23509557